SEARCH 

About Us   Business   Contacts   Employment   Fundraising   News   Research   Schools   Students   Events  ||  Site Map

Home  News 

NHMRC directs $10m to QIMR

QIMR scientists have received more than $10 million in funding from the latest round of National Health and Medical Research Council (NHMRC) project grants.
The QIMR projects include research that has the potential to improve human health from before birth and the effectiveness of vaccinations, as well as inform public health programs to prevent melanomas. 
The successful QIMR projects were:

  • Epigenetics – the next genetic frontier: Professor Emma Whitelaw, head of the Epigenetics Laboratory, received $1.2 million to explore epigenetics, the process by which cells differentiate and develop to create human embryos. 
  • Moliness and the genetic basis for melanoma risk: Professor Nicholas Martin, head of the Genetic Epidemiology Group, received $1.3 million to research how the genes that determine hair, eye and skin colour act to modify moliness and melanoma risk.
  • Endometrial cancer: Dr Amanda Spurdle, head of the Molecular Cancer Epidemiology Laboratory, received $1 million to identify the genetic risks of endometrial cancer in the general population.
  • Alcohol and nicotine addiction: Dr John Whitfield, from the Genetic Epidemiology Group, received $846,000 to study the genetics of alcohol and nicotine addiction.
  • Malaria: Dr Katharine Trenholme and Dr Donald Gardiner from the Malaria Biology Laboratory received $590,250 to undertake an analysis of a Plasmodium falciparum animopeptidase.
 
  • Haemochromatosis: Dr Daniel Wallace of the Membrane Transport Laboratory received $174,500 to research non-HFE haemochromatosis.
  • Indigenous Health: Dr Patricia Valery and others from the Indigenous Health Research Program were awarded $520,263 to continue investigations into Indigenous people and cancer survivorship.
  • Cell Trafficing: Dr David Harrich, head of the HIV Virology Laboratory, received $475,200 to research Tat Traffiing in Cells.
  • Malaria: Dr Denise L Doolan, head of the Molecular Vaccinology Laboratory, was awarded $434,250 to undertake protein microarrays for cross-species malaria vaccine development.
  • Iron Metabolism: Professor Gregory Anderson, head of the Iron Metabolism Laboratory, received $506,250 to investigate iron metabolism in the perinatal period.
  • Melanoma: Professor Nicholas Hayward, head of the Oncogenomics Laboratory received $389,500 to characterise genetic changes leading to melanoma development and Dr Graeme Walker, from the the same laboratory, was awarded $531,750 to research individual susceptibility to UVR-induced melanoma.
  • Lymphoma: Associate Professor Maher Gandhi, head of the Immunohaematology Laboratory, received $312,000 to continue his research into adoptive immunotherapy for lymphoma.
  • Migraine and Endometriosis: Dr Dale Nyholt and Dr Susan Treloar from the Genetic Epidemiology Laboratory were awarded $310,450 to undertake a genetic analysis of migraine in women with endometriosis.

www.nhmrc.gov.au/grants/rounds/index.htm

 

  • DNA Damage: Associate Professor Kum Kum Khanna and Dr Derek Richard from the Signal Transduction Laboratory received $622,000 in investigate SSB1 and DNA damage response.
  • Bowel Cancer: Dr Vicki Whitehall and Professor Barbara Leggett, head of the RBWH Gastroenterology Laboratory were awarded $284,250 to research tubulovillous adenomas in bowel cancer.
  • Bone Marrow Transplantation: Professor Geoff Hill, head of the Bone Marrow Transplantation Laboratory, received $521,250 to investigate the role of IL-17 in bone marrow transplantation.
  • New therapies: Professor Andrew Boyd, head of the Leukamia Foundation Laboratory was awarded $387,750 to explore new therapies for brain tumours.
October 23, 2008
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

 

Copyright © 2009 QIMR
Web Design
Use of this website is subject to
terms set out in our Legal Notice
webmaster@qimr.edu.au
Last Modified: Feb 03 2010